Search hospitals > Pennsylvania > Philadelphia
University of Pennsylvania
Claim this profilePhiladelphia, Pennsylvania 19104
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Heart Failure
Conducts research for Cancer
Conducts research for Lung Cancer
1932 reported clinical trials
267 medical researchers
Summary
University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Heart Failure, Cancer, Lung Cancer and other specialties. University of Pennsylvania is involved with conducting 1,932 clinical trials across 2,342 conditions. There are 267 research doctors associated with this hospital, such as Nimesh Desai, MD, Arati Desai, MD, Angela DeMichele, MD, and Wilson Szeto, MD.Top PIs
Nimesh Desai, MDUniversity of Pennsylvania5 years of reported clinical research
Studies Aortic Aneurysm
Studies Aortic Dissection
13 reported clinical trials
17 drugs studied
Arati Desai, MDAbrams Cancer Center of the University of Pennsylvania7 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
11 reported clinical trials
25 drugs studied
Angela DeMichele, MDAbramson Cancer Center of the University of Pennsylvania8 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
21 drugs studied
Wilson Szeto, MDThe Hospital of the University of Pennsylvania7 years of reported clinical research
Studies Aortic Aneurysm
Studies Thoracic Aortic Aneurysm
10 reported clinical trials
13 drugs studied
Clinical Trials running at University of Pennsylvania
Stroke
Heart Failure
Age-Related Macular Degeneration
Chronic Lymphocytic Leukemia
Atrial Fibrillation
Cystic Fibrosis
Carcinoid Tumor
Cancer
Flu
Breast Cancer
Anti-Coagulant + Anti-Platelet Therapy
for Stroke Prevention
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Recruiting2 awards Phase 36 criteria
Anticoagulation + Antiplatelet Therapy
for Post-Operative Atrial Fibrillation
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Recruiting2 awards Phase 32 criteria
Cognitive Outcomes
for Stroke
The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities that significantly affects daily functioning) after their stroke so that future treatments may be developed to improve outcomes in stroke patients. For this study, a "stroke" is defined as either (1) an acute ischemic stroke (AIS, or blood clot in the brain), (2) an intracerebral hemorrhage (ICH, or bleeding in the brain), (3) or an aneurysmal subarachnoid hemorrhage (aSAH, or bleeding around the brain caused by an abnormal bulge in a blood vessel that bursts). The investigators hypothesize that: 1. The size, type and location of the stroke play an important role in recovery of thinking and memory abilities after stroke, and pre-existing indicators of brain health further determine the extent of this recovery. 2. Specific stroke events occurring in individuals with underlying genetic or biological risk factors can cause further declines in brain heath, leading to changes in thinking and memory abilities after stroke. 3. Studying thinking and memory alongside brain imaging and blood samples in patients who have had a stroke allows for earlier identification of declining brain health and development of individualized treatment plans to improve patient outcomes in the future.
Recruiting1 award N/A6 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Pennsylvania?
University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Heart Failure, Cancer, Lung Cancer and other specialties. University of Pennsylvania is involved with conducting 1,932 clinical trials across 2,342 conditions. There are 267 research doctors associated with this hospital, such as Nimesh Desai, MD, Arati Desai, MD, Angela DeMichele, MD, and Wilson Szeto, MD.
Where is University of Pennsylvania located?
**Hospital of the University of Pennsylvania Directions:**
- To reach the Hospital of the University of Pennsylvania, take I-676 West to I-76 East (Schuylkill Expressway) and exit at 346-A (South Street). Turn right onto South Street to enter the campus.
**Pennsylvania Hospital Location:**
- Pennsylvania Hospital is situated at 800 Spruce Street, with the main entrance located on 8th Street.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Pennsylvania Hospital:
- Contact: 800-406-1177 or request online via MyLGHealth.
- Insurance inquiries: Contact Penn Medicine's insurance and billing department at 800-406-1177.
- Availability: Monday to Friday, 8:00 am to 6:00 pm EST; Saturday, 9:00 am to 1:00 pm EST.
What insurance does University of Pennsylvania accept?
The University of Pennsylvania Hospital accepts a wide range of insurance plans, including but not limited to Medicare Advantage, Pennsylvania Medical Assistance Managed Care (Medicaid), and Community HealthChoices (CHC). For Penn Cutaneous Pathology services, accepted insurances extend to Aetna, AmeriHealth, Keystone Health Plan East, and many others. Additionally, the Penn Student Insurance Plan (PSIP) through Aetna Student Health is available for most graduate and professional program students, meeting Penn's insurance requirements.
What awards or recognition has University of Pennsylvania received?
The University of Pennsylvania Hospital in Philadelphia is renowned for its clinical research studies, focusing on the prevention, diagnosis, and treatment of diseases. Its research laboratory specializes in imaging analytics, machine learning, pattern recognition, and computational imaging. This work is supported by the Pennsylvania Department of Health and NIH through multiple grants.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.